Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 22 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Goulis, Ioannis  [Clear All Filters]
Journal Article
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Oikonomou, I. Marios, Sinakos E., Antoniadis N., Goulis I., Giouleme O., Anifanti M., et al. (2022).  Effects of an active lifestyle on the physical frailty of liver transplant candidates.. World J Transplant. 12(11), 365-377.
Katsanos, G., Karakasi K-E., Antoniadis N., Vasileiadou S., Kofinas A., Morsi-Yeroyannis A., et al. (2022).  Enhanced recovery after surgery in liver transplantation: Challenges and feasibility.. World J Transplant. 12(7), 195-203.
Protopapas, A. A., Papagiouvanni I., Fragkou N., Alevroudis E., Sinakos E., & Goulis I. (2020).  Estimation of glomerular filtration rate in patients with cirrhosis: evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate.. Eur J Gastroenterol Hepatol.
Cholongitas, Ε., Koukoufiki A., Pipili C., Antoniadis N., Fouzas I., Haidich A-B., et al. (2019).  Is everolimus linked to metabolic syndrome in liver transplant recipients?. Indian J Gastroenterol. 38(4), 348-355.
Cholongitas, Ε., Goulis I., Theocharidou E., Antoniadis N., Fouzas I., Giakoustidis D., et al. (2014).  Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience.. Hepatol Int. 8(1), 137-45.
Imvrios, G., Vrochides D., Papanikolaou V., Fouzas I., Antoniadis N., Giakoustidis D., et al. (2011).  HCC influence on patient survival after liver transplantation for HDV cirrhosis.. Hepatogastroenterology. 58(110-111), 1654-8.
Soulaidopoulos, S., Goulis I., Giannakoulas G., Panagiotidis T., Doumtsis P., Karasmani A., et al. (2017).  Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis.. Ann Gastroenterol. 30(2), 225-231.
Oikonomou, T., Goulis I., Soulaidopoulos S., Karasmani A., Doumtsis P., Tsioni K., et al. (2017).  High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis.. Ann Gastroenterol. 30(2), 217-224.
Pyrpasopoulou, A., Pitsava G., Iosifidis E., Imvrios G., Massa E., Mouloudi E., et al. (2018).  Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria.. J Infect. 77(5), 448-454.
Pachiadakis, I., Choksi S., Ilonidis G., Akriviadis E., & Goulis I. (2013).  Letter to the editor concerning the paper: Boltjes A, Op den Brouw ML, Biesta PJ, et al. Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients [Molecular Immunolog. Mol Immunol. 56(1-2), 129-30.
Cholongitas, E., Goulis I., Antoniadis N., Fouzas I., Imvrios G., Papanikolaou V., et al. (2014).  New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.. Transpl Int. 27(10), 1022-8.
Sinakos, E., Antoniadis N., Goulis I., Cholongitas E., Kiapidou S., Tsakni E., et al. (2016).  Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.. Ann Gastroenterol. 29(2), 208-13.
Goulis, I., Karatapanis S., Akriviadis E., Deutsch M., Dalekos G. N., Raptopoulou-Gigi M., et al. (2015).  On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients.. Liver Int. 35(5), 1540-8.
Cholongitas, E., Antoniadis N., Goulis I., Fouzas I., Vasiliadis T., Akriviadis E., et al. (2016).  Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.. Liver Transpl. 22(1), 132-3.
Marshall, A. D., Cunningham E. B., Nielsen S., Aghemo A., Alho H., Backmund M., et al. (2018).  Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.. Lancet Gastroenterol Hepatol. 3(2), 125-133.
Soulaidopoulos, S., Cholongitas E., Giannakoulas G., Vlachou M., & Goulis I. (2018).  Review article: Update on current and emergent data on hepatopulmonary syndrome.. World J Gastroenterol. 24(12), 1285-1298.
Soulaidopoulos, S., Cholongitas E., Giannakoulas G., Vlachou M., & Goulis I. (2018).  Review article: Update on current and emergent data on hepatopulmonary syndrome. World Journal of Gastroenterology. 24(12), 1285 - 1298.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Doumtsis, P., Oikonomou T., Goulis I., Zachou K., Dalekos G., & Cholongitas E. (2018).  Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia.. Ann Gastroenterol. 31(1), 123-126.
Karkos, C. D., & Goulis I. (2018).  An Unusual Cause of Haematemesis.. Eur J Vasc Endovasc Surg. 55(5), 656.
Cholongitas, E., Goulis I., Ioannidou M., Soulaidopoulos S., Chalevas P., & Akriviadis E. (2017).  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.. Hepatol Int. 11(3), 306-314.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές